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Background: Pharmaceuticals, like antiepileptic drugs, are found regularly in surface waters, and consequently,
advanced waste water treatment technologies are discussed for substance elimination. Because antiepileptic drugs
have shown to transform to more toxic substances, their behavior in these treatment processes and resulting
effects on ecotoxicity should be investigated. To validate if waste water from an epilepsy ward of a neurological
hospital is appropriate for these investigations, it was treated with a membrane bioreactor (MBR), analyzed for
antiepileptic drugs and screened for ecotoxicological effects with Danio rerio embryos. Further, the behavior of
antiepileptic drugs in MBR treatment was estimated.
Results: Treatment of raw hospital waste water by the pilot scale MBR was successful regarding the low dissolved
organic carbon concentration in the effluent and allowed ecotoxicological testing with D. rerio. According to the
estimated behavior, partial elimination of 10-hydroxy-10,11-dihydrocarbamazepine (10-OH carbamazepine) and
rufinamide and some release of lamotrigine, oxcarbazepine and, possibly, primidone occurred. The other
investigated substances did not considerably change concentrations due to treatment. The highest concentrated
substances found were 10-OH carbamazepine, lamotrigine, and oxcarbazepine. The complex mixture of the
treated waste water had no effect on D. rerio morphology and did not change its primary and secondary motor
neurons (indicator for developmental neurotoxicity). Oxcarbazepine did not show morphological effects on D. rerio
at 8.7 mg L−1.
Conclusions: Biological treatment was not sufficient to significantly eliminate the load of antiepileptic drugs
investigated. No effects on D. rerio embryos were observed. Biologically treated waste water, originating from an
epilepsy ward, is appropriate for the investigation of the fate of antiepileptic drugs in advanced treatment
processes.
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Table 1 Maximum concentrations of pharmaceuticals in
municipal WWTP effluents and rivers
Analyte Concentration at WWTP
effluents (μg L−1)
Concentration in rivers
and streams (μg L−1)
Lipid regulators
Bezafibrate 4.6 [3] 3.1 [3]
Gemfibrozil 1.5 [3] 0.51 [3]
Metabolites of lipid regulators
Clofibric acid 1.6 [3] 0.55 [3]
Fenofibric acid 1.2 [3] 0.28 [3]
Antiphlogistics
Diclofenac 2.1 [3] 1.2 [3]
1.76 [4]
Acetylsalicylic
acid
12.1 [4]
Ibuprofen 3.4 [3] 0.53 [3]
Acetaminophen 6.0 [3] n.d. [3]
Mefenamic acid 1.36 [4]
Paracetamol 24.5 [5] 1.5 [5]
Tramadol 97.6 [5] 5.97 [5]
Metabolites of antiphlogistics
Salicylic acid 0.14 [3] 4.1 [3]
Gentisic acid 0.59 [3] 1.2 [3]
Betablockers
Metoprolol 2.2 [3] 2.2 [3]
Bisoprolol 0.37 [3] 2.9 [3]
Stimulant
Caffeine 3.18 [4]
Antibiotics
Lincomycin 45.7 [4]
Sulfathiazole 2.77 [4]
Trimethoprim 2.0 [4]
Ciprofloxacin 2.05 [4]
H2 receptor antagonist
Cimetidine 9.4 [5] 0.2 [5]
Antiepileptic drugs
Gabapentin 42.6 [5] 1.9 [5]
Carbamazepine 6.3 [3] 1.1 [3]
21.6 [4] 0.3 [5]
4.6 [5]
n.d., no data; WWTP, waste water treatment plant. Data were taken from the
reviews and screenings [3,6-8]. Empty fields: concentrations are not given in
[3,6-8].
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The first findings of pharmaceuticals, an important group
of anthropogenic compounds, in the environment occurred
in the 1970s (e.g., by Garrison et al. [1] and Hignite et al.
[2]). Since then, pharmacologically active compounds were
reported in numerous studies investigating rivers and
lakes, as well as ground and drinking water.
Pharmaceuticals are excreted after administration in
metabolized and unmetabolized forms, and subsequently
reach waste water treatment plants (WWTPs) via sewer
networks. Many pharmaceuticals are not sufficiently
eliminated in WWTPs; thus, they reach receiving waters.
Exemplary, concentrations of pharmaceuticals found in
WWTP effluents and rivers are compiled in Table 1.
In order to assess the possible effects of substances on
organisms, different ecotoxicological test systems are
used; test systems for aquatic organisms include bac-
teria, algae, crustacean, and fish. Effect concentrations
below 1,000 μg L−1 for pharmaceuticals found in WWTP
effluents and rivers (Table 1) are given in Table 2. Effect
concentrations found in ecotoxicological tests are in the
range of environmental concentrations for the substance
groups such as lipid regulators (bezafibrate), antiphlogistics
(diclofenac), betablockers (metoprolol), and antiepileptic
drugs (carbamazepine).
Due to numerous data on pharmacologically active
compounds in the environment and the rising concern
about possible chronic effects on aquatic organisms,
treatment processes for elimination of these compounds
were investigated. To improve elimination rates in
WWTPs, not only the influence of sludge age and dos-
ing of activated charcoal but also advanced treatment
processes like ozonation, chlorination, UV-radiation, and
combinations such as ozone/UV and H2O2/UV were in-
vestigated and discussed (e.g., [18-20]). Because oxida-
tion processes can lead to the formation of toxic
degradation products, possible effects of advanced treat-
ment processes were investigated (e.g., by [21-23]).
The formation of toxic degradation products in advanced
treatment processes was shown for the antiepileptic drugs
carbamazepine and oxcarbazepine (e.g., by [24-27]). In
[26], the authors found an elevation of acute toxicity on
Daphnia magna due to UV treatment of oxcarbazepine,
as they presumed, due to the formation of acridine. In
[27], the authors found similar results for UV treatment of
carbamazepine.
The prevalence of epilepsy is estimated at 0.91%, and
antiepileptic drugs were used by 634,566 patients in
Germany in 2009 according to [28]. Since most epilepsy
patients are in ambulant treatment, antiepileptic drugs
can be detected in most, if not all, WWTP effluents,
though data do not exist for all antiepileptic drugs.
Hence, chemical transformations of antiepileptic drugs,
which will occur if advanced treatment processes areused, will probably influence the toxicity of waste water.
To assess this possible influence, an investigation and
treatment of waste water loaded with antiepileptic drugs
and corresponding metabolites should be done. The
Table 2 Toxicological data for substances of Table 1 with effect concentrations below 1,000 μg L−1
Test Species Endpoint (time) Endpoint Effect concentration (μg L−1)
Bezafibrate
Mussels D. polymorpha LOEC (7 days) piGST transcript expression 0.236 [9]
Diclofenac
Fish (adult) O. mykiss LOEC (28 days) Cytophathology of the liver, kidney, and gills 1 [10]
Metoprolol
Fish (adult) O. mykiss LOEC (28 days) Cytopathology of the liver 1 [11]
Carbamazepine
Rotoxkit (rotifers) B. calyciflorus LOEC (48 h) Reproduction 754 [12]
Phytoplankton S. obliquus EC50 (30 days) Chlorophyll a synthesis 800 [13]
Crustaceans G. pulex LOEC (1.5 h) Behavior 0.01 (ns) [14]
C. dubia LOEC (7 days) Reproduction 100 [12]
Mussels M. galloprovincialis LOEC (7 days) Membrane stability 0.1 [15]
Fish (adult) D. rerio LOEC (6 weeks) Egg production, oocytes, and kidney 0.5 [16]
D. rerio LOEC (3, 7, and 15 days) DNA integrity 0.31 [17]
C. carpio LOEC (28 days) Cytopathology of the kidney 1 [11]
LOEC lowest observed effect concentration, ns not significant.
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and its dilution should be as low as possible.
For an effective ozonation, a low concentration of
dissolved organic carbon (DOC) is important [29], and
this is most likely true for other oxidative treatment
processes. Therefore, the waste water loaded with
antiepileptic drugs should be treated biologically prior to
advanced treatment steps. A membrane bioreactor (MBR)
is appropriate to eliminate DOC and additionally, due
to filtration, emits only a small amount of suspended
particles (which interfere with irradiation and oxidative
processes).
In the study presented here, a hospital ward, special-
ized on epilepsy treatment, was chosen as source for
waste water highly loaded with antiepileptic drugs. The
waste water was treated biologically, analyzed for
antiepileptic drugs, and tested for ecotoxicological ef-
fects. A standard test system for the assessment of
ecotoxicity of treated waste water is the zebrafish (Danio
rerio) embryo test [30,31]; additional endpoints are given
in [32] and other publications. The central nervous sys-
tem (CNS) of zebrafish has similarities with the human
CNS, and some mammalian neurotransmitter systems
are present [33]; the site of action of antiepileptic drugs
is the human CNS.
Although the concentrations of antiepileptic drugs to
be expected in the hospital waste water would not reach
the effect concentrations for antiepileptic drugs on D.
rerio (Table 3), possible effects of this complex mixture
should be investigated. On the one hand, ecotoxico-
logical data exist only for carbamazepine and phenytoin;
on the other hand, according to [34], substances withsimilar targets can add their effects to each other and
cause effects below the single substance effect concentra-
tions. Due to the expected low dilution, possible additive
effects, the incomplete data in the existing literature, and
the similarity of CNS, toxic effects on D. rerio embryos
seemed possible and worth investigating.
Because antiepileptic drugs take effect on the neuronal
system and show some neurotoxicological effects (e.g.,
[37]), the biologically treated waste water was also tested
with a newly introduced test for developmental neuro-
toxicity with D. rerio according to [38], where the motor
neurons are stained.
To validate, if the chosen waste water is appropriate
for further investigation of advanced treatment pro-
cesses, the following steps were performed:
 Waste water loaded with antiepileptic drugs was
treated with a MBR.
 Concentrations of antiepileptic drugs were
determined in order to assess potential variations
due to MBR treatment.
 Ecotoxicological tests with D. rerio were applied to
MBR-treated waste water.
 In order to assess the developmental
neurotoxicological effects in D. rerio, motor neurons
were stained.
To our knowledge, this is the first work regarding
biologically treated waste water of a ward in a neuro-
logical hospital specialized on epilepsy treatment which
is screened for antiepileptic drugs and tested with D. rerio
embryos.
Table 3 Toxicological data for antiepileptic drugs, investigated in this study, regarding D. rerio embryo test
Test Species Endpoint (time) Endpoint Effect concentration (μg L−1)
Carbamazepine
Fish (early life stage) D. rerio LOEC (10 days) Embryos and larvae mortality 50,000 [12]
EC50 (72 h) Growth retardation 86,500 [35]
EC20 (72 h) Tail malformation 17,500 [36]
EC50 (72 h) Tail malformation 52,500 [36]
Phenytoin
Fish (early life stage) D. rerio EC20 (72 h) Tail malformation 10,000 [36]
EC50 (72 h) Tail malformation 97,400 [36]
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Characterization of the raw waste water
The results for the chemical oxygen demand (COD),
given in Additional file 1: Table af1, show a high hetero-
geneity of the sampled raw waste water. This may be
explained by the frequency of toilet flushes and occur-
rence of feces.
Biological treatment
Since the purpose of the biological treatment is the re-
duction of readily biodegradable substances and DOC
concentration, no process monitoring was performed.
The weighted mean of the COD was 222 mg L−1. The
mean dried matter content of 2.1 g L−1, the reactor vol-
ume of 107 L, and a load of 315 L raw waste water in 10
days resulted in a biochemical oxygen demand (BOD5)
load of 16 mg BOD5 (g TS)
−1 day−1 (assuming a COD/
BOD5 ratio of 2:1). The membrane flux was approxi-
mately 21 L (h bar m2)−1. The detention period of theor-
etically 80 h was much higher than the typical 8 h of a
municipal waste water treatment plant.
Characterization of the biologically treated waste water
The total amount of biologically treated waste water was
approximately 320 L. The modeled fractions originating
from raw waste water of the hospital was 59%. The bio-
logically treated waste water, stored at 4°C, showed a
concentration of dissolved organic carbon of 5 to 6 mg L−1
(quadruple determination), a pH of 7.3, and an electrical
conductivity of 0.71 ms cm−1 (single determinations). The
results of the multi-elemental analysis (single determin-
ation), given in Additional file 1: Table af2, show a low Cu
load, which is important for ecotoxicological test systems.
Estimation of the behavior of antiepileptic drugs during
MBR treatment
Based on the measured concentrations of antiepileptic
drugs in the raw waste water samples and their modeled
fractions of the biologically treated waste water, the con-
centrations to be expected in the mixed sample after
MBR passage without transformation were calculated.These modeled concentrations were compared to the
concentrations measured in the biologically treated waste
water in Figure 1. The underlying results of raw waste
water samples, given in Additional file 1: Figure af1, show
high variations of antiepileptic drug concentrations over
time.
For interpretation of Figure 1, it has to be taken into ac-
count that the measured concentrations are based on sin-
gle determinations. Additionally, raw waste water contains
much higher concentrations of organic compounds, which
could overload the solid phase extraction (SPE) cartridges
and cause matrix effects in the mass spectrometer. The
internal standard 10,11-dihydrocarbamazepine was used
to account for cartridge capacity. Because the aim of the
analysis was to perform an estimation on the behavior
and the expected analyte concentrations were high, the
use of surrogate standards for elimination of possible
matrix effects was omitted.
According to the estimation, partial elimination of 10-
hydroxy-10,11-dihydrocarbamazepine (10-OH carbamaze-
pine) and rufinamide and some release of lamotrigine,
oxcarbazepine and, possibly, primidone occurred. The
other investigated substances did not distinctly change
concentrations due to this biological treatment in the
MBR.
The elimination of 10-OH carbamazepine is contrary
to the findings in [39], wherein the authors found a release
of 10-OH carbamazepine in a WWTP. For lamotrigine,
no data about its behavior in WWTP were found in the
literature, but the authors in [40] found a large portion of
lamotrigine in WWTP effluent in the 2-N-glucuronidated
form (see Table 4). Deglucuronidation, which occurs in
WWTPs (e.g., [41]), presumably led to the release of
lamotrigine. The release of oxcarbazepine is also contrary
to the literature; in [39], the authors found an elimination
rate of 25% to 73% in WWTPs. In [42], the authors found
no elimination of primidone and a release of phenyle-
thylmalonamide and phenobarbital in a WWTP, which
is in general accordance with the presented data. For
rufinamide, lamotrigine, lacosamide, and zonisamide,
no data were found in the literature.
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Figure 1 Comparison of modeled and measured concentrations for biologically treated waste water. Modeled concentrations consist of
results from raw waste water samples and their fractions on the biologically treated waste water.
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resulted from missing sunlight under pilot scale condi-
tions, since UV leads to degradation of oxcarbazepine ac-
cording to [26]. Additionally to missing sunlight, the low
BOD5 load may have resulted in lower co-metabolization
rates (e.g., [47]). However, results of oxcarbazepine showed
a high variation (see Figure 2) and should be considered
carefully.
The results suggest that biological treatment with the
membrane bioreactor was not sufficient to considerably
eliminate the antiepileptic drugs investigated, which is
(fate of oxcarbazepine excepted) in good agreement with
the data found in the literature.
In prospective biological treatments of loaded raw
waste water, the dilution, caused by starting conditions
of the MBR and sludge exchange, should be minimized
by the use of a smaller reactor volume, bigger membrane
area, and higher BOD5 load. Sludge exchange should be
avoided, if possible.
Antiepileptic drugs in the biologically treated waste
water
Due to single determinations, the results of the previous
analysis of biologically treated waste water are of limited
significance. Therefore, the analysis of the stored (4°C),biologically treated waste water was repeated with four
different SPE procedures.
The calibration points using hydrophilic-lipophilic
balance (HLB) and polar enhanced polymer (PEP) SPE
cartridges were generally in good accordance so that
they were used together in the calibration curve. The
only exception was ethosuximide, whose mean recovery
rate in SPE extraction was 38% with a high variation.
Nevertheless, both SPE calibration points were used, to
include the recovery rate, and the directly injected stan-
dards were discarded from the calibration curve of
ethosuximide.
The results of the analysis are shown in Figure 2. The
highest concentrated substances were 10-OH carba-
mazepine (which is a metabolite of carbamazepine and
oxcarbazepine), lamotrigine, and oxcarbazepine.
Contrary to the previous analysis, now ethosuximide
could be detected in the biologically treated waste water.
The reason lies presumably in the low recovery rate,
which may have led to a cartridge breakthrough due to
the higher preconcentration factor in the previous ana-
lysis. Apart from that, the results for the biologically
treated waste water obtained under the use of the two
different SPE cartridges are in good agreement with the
previous results (oxcarbazepine excepted).
Table 4 Maximum concentrations of antiepileptic drugs
used in this study in municipal WWTP effluents and
rivers
Analyte Concentration at
WWTP effluents
(μg L−1)
Concentration in
rivers and streams
(μg L−1)
Carbamazepine 6.3 (DE) [3] 1.1 (DE) [3]
21.6 (KR) [4] 0.3 (UK) [5]
4.6 (UK) [5]
Ethosuximide No data No data
Phenylethylmalonamide 0.37 (DE) [43] 0.11 (DE) [43]
Lamotrigine 0.488 (USA) [40] 0.108 (USA) [40]
1.2 (USA) [6]
Lamotrigine 2-N-glucuronide 0.209 (USA) [40] 0.195 (USA) [40]
Lacosamide No data No data
Primidone 0.71 (DE) [43] 0.18 (DE) [43]
Zonisamide No data No data
Sulthiame No data No data
Felbamate No data No data
10-OH-Carbamazepine 1.17 (FR) [39] No data
1.9 (USA) [6]
N-Desmethylmethsuximide No data No data
Oxcarbazepine 0.129 (FR) [39] No data
0.48 (USA) [6]
Rufinamide No data No data
Phenytoin 0.25 (USA) [44] 0.004 (USA) [45]
Metabolites of antiepileptic drugs
Phenobarbital 0.21 (DE) [43] 0.05 (DE) [43]
Carbamazepine epoxide 0.029 (FR) [39] 0.077 (NO) [46]
Exemplary data, not exhaustive. FR France, DE Germany, KR Republic of Korea,
NO Norway, USA United States of America.
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substances was approximately 400 μg L−1, which is more
than 15-fold higher than to be expected at WWTP efflu-
ents in Europe or the USA according to concentrations
given in Table 3 (the mean concentration of 1 μg L−1
was assumed for substances without existing data). Con-
sidering the modeled portion of 59% hospital raw waste
water in the biologically treated waste water, this rough
estimation would result in a 25-fold higher load.
This confirms the low dilution due to missing rain
water and due to the homogeneity of the group of pa-
tients. However, the contribution of the ward to the
mass flow of the corresponding waste water treatment
plant will be low due to the widespread use of anti-
epileptic drugs.
Due to the low concentration of dissolved organic car-
bon and the relatively high load of antiepileptic drugs,
this biologically treated waste water, originating from an
epilepsy ward, is appropriate for the investigation of thebehavior of antiepileptic drugs in advanced waste water
treatment processes.Embryo tests on biologically treated waste water
No morphological differences between the embryos ex-
posed to biologically treated waste water and the con-
trols in tests with durations of 48, 72, and 96 h could be
detected. The overall mortality in valid tests was less
than 7%. The results of heartbeat frequency after 96 h
are shown in Figure 3.
Oxcarbazepine solution was used for comparison with
a highly concentrated antiepileptic drug. The tested
oxcarbazepine solution was saturated at 26°C; a solubil-
ity test showed a concentration of 8.7 ± 0.3 mg L−1.
Toxicity tests of 10-OH carbamazepine and lamotrigine,
which were also present at high concentrations in the
biologically treated waste water, should be performed
with D. rerio. There were no significant differences re-
garding the primary and secondary motor neurons be-
tween embryos treated with biologically treated waste
water and the control.
Weigt et al. [36] have shown that D. rerio embryos are
able to metabolize (and therefore activate) proteratogens
and conclude from their results that D. rerio embryos
show phase I enzymatic activity at very early develop-
mental stages. Therefore, a metabolization of test com-
pounds during the test can be assumed. It should be
tested if there is a significant change of antiepileptic
drug concentrations due to metabolization.
Until now, only a small amount of ecotoxicological
data exist for antiepileptic drugs in the literature (excep-
tion: carbamazepine). Therefore, additional ecotoxico-
logical tests should be conducted on this biologically
treated waste water. A test system probably sensitive
enough to show effects (derived from its sensitivity to
carbamazepine) is Mytilus galloprovincialis [15], although
this is a salt water organism.
For the investigation of advanced waste water treat-
ment processes, the micro-algae Nitzschia sigma should
additionally be tested because of its sensitivity to acridine
(EC50 growth inhibition 80 μg L
−1 [48]).Conclusion
Biological treatment of the raw hospital waste water by a
pilot scale membrane bioreactor was successful regard-
ing the low dissolved organic carbon concentration and
low oxygen consumption in the treated water. This
allowed ecotoxicological testing of this highly contami-
nated water with embryos of D. rerio.
Biological treatment caused some elimination of 10-OH
carbamazepine and rufinamide but was not sufficient for
significant elimination of the load of antiepileptic drugs
investigated, which is in general accordance with the
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http://www.enveurope.com/content/25/1/29literature. The highest concentrated substances found were
10-OH carbamazepine, lamotrigine, and oxcarbazepine.
The complex substance mixture of the treated waste
water from a ward located in a neurological hospital,
which is specialized on epilepsy treatment, had neither
toxic effects on D. rerio morphology nor on the develop-
ment of the primary and secondary motor neurons (indi-
cator for developmental neurotoxicity). An oxcarbazepine
solution of 8.7 ±0.3 mg L−1 had no morphological effects
on D. rerio embryos. Biologically treated waste water
originating from an epilepsy ward is appropriate for in-
vestigation of the fate of antiepileptic drugs in advanced
treatment processes.
Methods
Waste water sampling
Sampling took place on Thursday, 28 June 2012, a hot
dry summer day, from 12:05 p.m. until 16:30 p.m. at the
waste water collector from an epilepsy ward and an epi-
lepsy ambulance of an anonymous neurological hospital
in Germany. The water was pumped out of the sewer
with two 10-mm polytetrafluoroethylene (PTFE) tubes
aligned parallel to the flow direction. A small barrier, lo-
cated approximately 5 cm behind the openings of the
tubes, was used to slightly raise the water level. With
this strategy the more or less constantly flowing dilution
water (e.g., from basins) was mainly discarded, and only
the water of the toilet flushes was collected.
Because the concentrations of antiepileptic drugs to be
expected depend on the patients present during sam-
pling time, a generally high variability will occur. As a
result of regular plugging of the tubes due to toilet paper
and feces, continuous control of the pump was neces-
sary. The aim of this sampling was to get waste waterMembrane
bioreaktor
Compressed
air
L
Level
sensor
Canister Compressed
air
Pump
M
Figure 4 Flow chart of the membrane bioreactor.highly loaded with antiepileptic drugs and not the de-
scription of representative mass flows of antiepileptic
drugs from this hospital ward. Therefore, the sampling
was done in 1 day. A total volume of ca. 320-L raw waste
water was collected in new, RO water cleaned low-density
polyethylene (LD-PE) canisters (9 × 25 L, 3 × 30 L, filled
above the nominal mark) and stored until treatment
at 4°C.
Waste water treatment
The raw waste water was treated in a MBR with a ceramic
membrane (200-nm pore size, Type G 200, kindly pro-
vided by ITN Nanovation AG, Saarbrücken, Germany).
The flow chart of the MBR is shown in Figure 4. All mate-
rials with direct water contact after membrane passage
were of PTFE, stainless steel, high-density polyethylene
(HD-PE), or (in case of the membrane housing) polyether-
sulfone (PES) and polyurethane (PU). The treatment cycle
was as follows: After starting the re-filling process of
the MBR with raw waste water, the aeration stopped for
30 min to reach anoxic conditions. Then, 2:30-min fil-
tration with 0:10-min pause continued cyclic under con-
stant aeration until the filtrate box was filled (5 L,
duration ca. 3 h), which triggered the re-filling of the
MBR. Re-filling was performed with a peristaltic pump
from the clear supernatant of the raw waste water; the
particle loaded bottom was discarded. The MBR had a
volume of 107 L and was constantly stirred. It was ini-
tially filled with activated sludge from the last aeration
tank before the clarifier of the waste water treatment
plant in Giessen, Germany. Prior to use, it was washed
twice with tap water via sedimentation to reduce the
impact of the municipal waste water. The treatment was
conducted in three separate batches (2.5, 4, and 3 days,HD-PE reservoir
600 L
Filtrate
box
Vacuum box
L
Level
sensor Vacuum
 pum
p
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http://www.enveurope.com/content/25/1/29respectively), for which fresh sludge was used; the
decanted water of the prior batch was reused to reduce
dilution of the waste water. The biologically treated
waste water was collected in a 600-L HD-PE reservoir,
which was aerated during treatment, and then stored at
4°C until further use. The term biologically treated
waste water used in this publication refers to this mixed
sample.
Water analysis
The COD of filtrated (0.45-μm polyethylene terephtha-
late (PET)) raw waste water samples, which were stored
frozen before analysis, was quantified with cuvette tests
(Hach-Lange, Düsseldorf, Germany). The DOC of the
biologically treated waste water, which was stored at 4°C
until analysis, was tested with cuvette tests (Hach-Lange).
The cations of the biologically treated waste water were
analyzed with an ICP-OES (720-ES, Varian, Darmstadt,
Germany).
Estimation of antiepileptic drug degradation due to
biological treatment
To allow the assessment of a possible biological degrad-
ation of antiepileptic drugs during MBR treatment, raw
waste water and biologically treated waste water were
analyzed for these substances. For preconcentration and
cleanup, Oasis HLB (60 mg, 3 mL) SPE cartridges condi-
tioned with 5 mL methanol and equilibrated with 5 mL
Milli-Q (Merck Millipore, Darmstadt, Germany) water
were used. The samples of raw waste water (stored at −32°C)
were thawed; the treated waste water (stored at 4°C) was
brought to room temperature. Twenty-five milliliters of
decanted, unfiltrated samples were spiked with 50-μL so-
lution of 10,11-dihydrocarbamazepine (12.5 mg L−1) for
internal standardization and forced, via peristaltic pump,
through the cartridges with 1 ml min−1. For identification
and calibration of the analytes, ClinCal® serum calibrators
15013 and 15213 (Recipe, Germany) were diluted, mixed
together, spiked with internal standard, and prepared as
waste water samples to get a 2-point calibration with
preconcentration factors of 0.6 and 0.3 for 15013 and 0.4
and 0.2 for 15213.
After extraction, the cartridges were dried for 30 min
under vacuum and then eluted with 5 mL acetonitrile.
The extract was evaporated to dryness under a gentle
stream of nitrogen at room temperature. The analytes
were then resolved in 200 μL acetonitrile. After thor-
ough rinsing of all surfaces, 300 μL Milli-Q water was
added; the sample was mixed and then filtrated with
0.45-μm PTFE syringe filters. Calibration points were
prepared twice and samples once.
For each raw waste water sample, the fraction on the
biologically treated waste water was modeled, based on
the canister volume, time of introduction in the MBR,the sludge exchanges (after 2.5 and further 4 days, in
which 47 L of water and sludge were exchanged due to
treatment break), and removal from the system due to
filtration. The fraction of each raw waste water sample
on the biologically treated waste water was calculated
with the sum of filtrated volumes. A water loss (without
analyte loss) of 20 L due to evaporation was assumed.
These modeled fractions were used to calculate the
concentrations of antiepileptic drugs to be expected in
the mixed sample after MBR passage considering the
abovementioned factors without any transformation
process.
Antiepileptic drugs in biologically treated waste water
To confirm the concentrations of antiepileptic drugs in
the biologically treated waste water, an additional screen-
ing with two different SPE cartridges and a lower
preconcentration factor was applied. Additionally to the
uncontrolled conditions, the same conditions as in high-
performance liquid chromatography (HPLC) gradient
(0.1% formic acid) were used, resulting in a pH below 2.8.
For preconcentration and cleanup, Oasis HLB (60 mg,
3 mL) and Thermo HyperSep Retain PEP (60 mg, 3 mL)
SPE cartridges, each conditioned with 5 mL methanol
and equilibrated with 5 mL Milli-Q water, were used.
For sample extraction, 10 mL of treated waste water
were mixed with 15 mL Milli-Q water and forced via
peristaltic pump through the cartridges with 1 ml min−1.
Drying, elution, evaporation, resolving, and filtration
were performed as described above.
For identification and calibration of the analytes, Clintest®
standards 15011, 14011, and 14111 (Recipe, Germany) were
used. While 15011 was diluted and then preconcentrated
like waste water samples (preconcentration factor 1,
1× HLB, 1× PEP), 14011 and 14111 were measured
without further preparation.
Mass spectrometric analysis of antiepileptic drugs
Antiepileptic drugs and pharmacologically active metab-
olites were measured with liquid chromatography/time-
of-flight mass spectrometry (LC-TOF-MS) consisting of
a Dionex Ultimate 3000 HPLC (Thermo Fisher Scien-
tific, Idstein, Germany) equipped with a Dionex Polar
Advantage II column (2.1 × 150 mm, 3 μm). The detection
was performed with a Bruker micrOTOF-QII (Bremen,
Germany) in positive electrospray ionization (ESI) mode
with a mass range of 50 to 500 m z−1; for mass calibration,
Li formate was used.
The mobile phase consisted of 0.1% formic acid (FA)
in Milli-Q water (A) and 90% acetonitrile with 10% of
0.1% FA in Milli-Q water (B); the gradient of A was 0
min 91%, 5 min 83%, 15 min 75%, 25 min 55%, 30 min
55%, 35 min 20%, 45 min 20%, 47 min 91%, and 60 min
91%. Identification of the analytes was performed with
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erature given in Table 5 and (in case of equal masses)
the elution order. To eliminate noise and artifacts as
good as possible, the exact masses given in Table 5 were
determined with the standards, and the mass window
for quantification was set to ±0.01 m z−1.
Solubility of oxcarbazepine
One of the toxicological tests was performed with a sat-
urated oxcarbazepine solution. To reconstruct this con-
centration, a solubility test was conducted. An excess
amount of oxcarbazepine (>98%, Sigma-Aldrich, St. Louis,
MO, USA) was mixed in moderately hard synthetic
freshwater [57] (target concentration 10 mg L−1) in a
light-protected flask. After agitation for 3 days at room
temperature, the solution was tempered 3 days at 26°C ±
1°C in a water bath without agitation. The solution was
filtrated with tempered syringe filters (0.45-μm PET) in
tempered vials four times, and each was diluted 1:1 with
methanol immediately to prevent precipitation. A 3-point
calibration (1, 5, and 10 mg L−1) was used. Concentrations
of oxcarbazepine were measured with an Agilent 1200
HPLC (Waldbronn, Germany); detection was performed
with a diode array detector (G1315B, Agilent) at 254.8 nm.
Column and gradient were the same as in LC-TOF-MS
analysis.Table 5 Mass windows used for the measured analytes
and concentrations found in the literature
Analyte Retention
time (min)
Used mass
window
(±0.01 m z−1)
Mass given in
the literature
Ethosuximide 6.6 142.085 142.0 [49]
Phenylethylmalonamide 6.7 207.112 207.0 [42]
Lamotrigine 9.1 256.013 256.1 [49]
Lacosamide 9.9 251.137 251.2 [50]
Primidone 10.1 219.111 219.1 [51]
Zonisamide 11.2 213.031 213.1 [49]
Sulthiame 11.5 291.044 291.0 [52]
Felbamate 12.9 178.085 178.2 [49,53]
10-OH-Carbamazepine 16.3 255.111 255 [54]
N-
Desmethylmethsuximide
17.2 190.086 190.1 [49]
Phenobarbital 17.8 233.090 231.2 [49], neg
Carbamazepine epoxide 19.2 253.095 253.2 [49]
Oxcarbazepine 21.4 253.095 253.1 [55]
Rufinamide 13.2 239.072 239.1 [56]
Carbamazepine 25.0 237.101 237.1 [49]
10,11-
Dihydrocarbamazepine
25.1 239.116
Phenytoin 27.2 253.095 253.2 [49]
neg negative polarity was used.Toxicological tests
Fish maintenance
Approximately one hundred D. rerio were maintained in
a 120-L tank at 26°C with 10:14-h light/dark cycle and
fed two times daily with Tetramin® (Tetra, Melle, Germany)
and once per workday with artemia. For egg production, a
spawning dish, covered with a stainless steel mesh and
artificial plants, was introduced in the tank before lights
out and removed 30 to 45 min after lights on at the day
of the test. The eggs were washed with control and then
randomly put in a beaker filled with 20-mL test solution
at the latest 2 h after lights on; from there, they were
sorted to the test vessels (4-mL glass vessels with 3-mL
test solution).
Tests with D. rerio
After controlling the vitality and morphology of the em-
bryos, the vessels were put into the incubator at 26°C
with 12:12-h light/dark cycle for the duration of the test.
The control was prepared as moderately hard synthetic
freshwater according to [57]. The test solutions were
brought to test temperature and vented for a minimum
of 15 min prior to exposition of the embryos. According
to [31], the pH of the sample and control was not ad-
justed, given that it was within the limits of 6.5 to 8.5.
For counting of the heartbeat, one vessel was removed
from the incubator, put without delay on the inverse
microscope (Olympus IM, Hamburg, Germany) for
counting and, after examination of the morphology, put
back into the incubator, so that the temperature of the
vessel while counting was the same for each embryo. All
examinations were done blinded.
Lethal endpoints, sublethal endpoints, and endpoints
of teratogenicity in the fish embryo test (FET) were se-
lected for 48 and 96 h according to [32] with emphasis
on the heartbeat frequency. Tests were treated as valid
when the mortality of the control was 10% or smaller.
Valid tests were conducted at 48 h (three samples +
control with 20 embryos; two samples + control with
15 embryosa), 72 h (three samples + control with 15
embryosa), and 96 h (two samples + control with 10
embryos). No repetitions were done.
For assessment of developmental neurotoxicity, also
the primary and secondary motor neurons of 48-h-old
embryos were stained and rated according to the me-
thod previously published by Muth-Köhne et al. [38]
which was adapted as follows: The fixed embryos were
permeabilized and directly blocked in blocking solution
(phosphate-buffered saline (PBS)/4% (v/v) Triton X-100/
10% (v/v) normal goat serum) for 30 min at room
temperature and constant agitation and then incubated
with the primary antibody (5 μg/mL in blocking solu-
tion) overnight at 4°C. The used chemicals and tools
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ation of the stained motor neurons and the rating of de-
fects were done blinded. The test was conducted at 48 h
(two samples + control with 15 embryos of which 13 to
14 were used).
Endnote
aEmbryos were controlled for vitality and then fixed;
morphology was assessed on fixed embryos.
Additional file
Additional file 1: Chemical oxygen demand, multi-elemental
analytics, and antiepileptic drug concentrations. Table af1. Chemical
oxygen demand (COD) of raw waste water samples. Table af2. Results of
multi-elemental analytics for biologically treated waste water with ICP-OES
(mg L−1). Figure af1. Antiepileptic drug concentrations for raw waste water
samples.
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